Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q4 2016 · 10-K
Revenue$571.50M$571.50M+0.2% vs Q4 2015 Net Income-$18.70M-$18.70MN/M vs Q4 2015 EPS Diluted-$0.63-$0.63N/M vs Q4 2015 Gross Profit$314,400,000+1.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$94,752,000+163.6% Free Cash Flowderived$49,639,000+523.2% Margins · derivedGross margin55.0%+0.9 pt vs Q4 2015
Operating margin-4.9%−15.4 pt vs Q4 2015
Net margin-3.3%−11.9 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 1, 2017 · 60 d after period end